Nearmap chief executive Dr Rob Newman said in an interview that his company was in fact changing tack from defence to offence when it came to defending its IP.“(The lawsuit) is not having an operational impact on our business,” Dr Newman said in an interview on Wednesday. “We’ve always said the case against us is without merit, but as we’ve looked into the intellectual property of EagleView, we believe that’s actually there’s some fundamental issues with their intellectual property.
“So we have actually filed what’s called an inter partes review. An IPR is the acronym with the patent office, and we’re actually challenging the validity of their patents. So we’ve kind of gone from a defensive stance to an offensive stance in regard to the litigation. And so that gives us good confidence that we will endure.”
NEA Price at posting:
$2.00 Sentiment: Buy Disclosure: Held
